<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04631978</url>
  </required_header>
  <id_info>
    <org_study_id>19102017-15/4-184</org_study_id>
    <nct_id>NCT04631978</nct_id>
  </id_info>
  <brief_title>Analysis of Retinochoroidal Vasculature in Underweight Women Using Optical Coherence Tomography Angiography</brief_title>
  <official_title>Analysis of Retinochoroidal Vasculature in Underweight Women Using Optical Coherence Tomography Angiography</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Akdeniz University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Akdeniz University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cachectic patients and controls undergoing a comprehensive ophthalmologic examination. The&#xD;
      imaging of all subjects is undertaken using a commercial OCTA device with a scan rate of&#xD;
      70,000 A-scans/s, scan beam wavelength of 840 ± 10 nm and bandwidth of 45 nm. All&#xD;
      measurements are performed between 10:00 and 12:00 on the same day. The OCTA images are&#xD;
      independently graded and assessed by two retinal specialists. The software automatically&#xD;
      segmented these full-thickness retinal scans into the superficial and deep inner retinal&#xD;
      vascular plexuses, outer retina, and choriocapillaris (CC). The vascular density in the&#xD;
      superficial and deep retinal vascular zones is calculated automatically by the software, and&#xD;
      the foveal avascular zone (FAZ) and foveal density (FD) are also automatically determined.&#xD;
      Choroidal thickness is calculated manually by two retinal specialists, and the average value&#xD;
      was used.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cachectic patients and controls undergoing a comprehensive ophthalmologic examination,&#xD;
      including the measurements of best-corrected visual acuity (BCVA), refractive error (KR-8900;&#xD;
      Topcon, Tokyo, Japan), intraocular pressure (IOP, Full Auto Tonometer TX-F; Topcon), axial&#xD;
      length (AL, Lenstar LS 900, Haag-Streit AG, Switzerland), slit lamp examination of the&#xD;
      anterior segment, dilated fundus examination, and OCTA imaging (Optovue RTVue XR 100 Avanti,&#xD;
      Freemont, California, USA) are included in the study. To calculate BMI, height is measured&#xD;
      using a standard anthropometric tape (Bioplus Stature Meter, model number IND/09/2005/815),&#xD;
      and a certified electronic weighing scale (model number Omron HN-283) is used to measure&#xD;
      weight.&#xD;
&#xD;
      According to the national guidelines, the patients are classified into two underweight&#xD;
      groups: Group 1 consisting of those with a BMI of &lt;17.00 kg/m2 and Group 2 comprising those&#xD;
      with a BMI of 17.00 to 18.49 kg/m2. The control group is formed with individuals with a&#xD;
      normal BMI (18.50 to 24.99 kg/m2).&#xD;
&#xD;
      The right eye of each participant is included in the study. If the right eye meets any of the&#xD;
      exclusion criteria, then the left eye is selected for the sample. The inclusion criteria for&#xD;
      the patient group is being underweight (BMI &lt; 18.50 kg/m2). The exclusion criteria for all&#xD;
      groups are as follows: refractive error &gt;+3.0 diopters (D) or &lt;-3.0 D spherical equivalent;&#xD;
      poor image quality &lt;60 due to unstable fixation; IOP &gt; 21 mm Hg; longer AL (&gt;25 mm);&#xD;
      pre-existing ophthalmic pathologies; prior ocular surgery; and a systemic chronic disease&#xD;
      that can cause underweight or retinopathy, such as cancer, malnutrition, and diabetes&#xD;
      mellitus.&#xD;
&#xD;
      OCTA&#xD;
&#xD;
      The imaging of all subjects is undertaken using a commercial OCTA device with a scan rate of&#xD;
      70,000 A-scans/s, scan beam wavelength of 840 ± 10 nm and bandwidth of 45 nm. This device can&#xD;
      perform 70 000 A-scans/s per second to acquire volumes of 304 × 304 A-scans. All measurements&#xD;
      are performed between 10:00 and 12:00 on the same day.&#xD;
&#xD;
      To evaluate the vascular structures, 6×6 mm OCTA software is used. The split-spectrum&#xD;
      amplitude decorrelation angiography (SSADA) algorithm is performed in all participants. The&#xD;
      images of poor quality (signal strength index (SSI) &lt; 8) with either significant motion&#xD;
      artifact or incorrect segmentation are excluded. The OCTA images are independently graded and&#xD;
      assessed by two retinal specialists. The software automatically segmented these&#xD;
      full-thickness retinal scans into the superficial and deep inner retinal vascular plexuses,&#xD;
      outer retina, and choriocapillaris (CC). The vascular density in the superficial and deep&#xD;
      retinal vascular zones is calculated automatically by the software, and the foveal avascular&#xD;
      zone (FAZ) and foveal density (FD) are also automatically determined. The same software also&#xD;
      calculates the flow index rates in a central circular zone of 3.144 mm² in the outer retina&#xD;
      and CC segments. Choroidal thickness is calculated manually by two retinal specialists, and&#xD;
      the average value was used.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 1, 2020</start_date>
  <completion_date type="Actual">August 30, 2020</completion_date>
  <primary_completion_date type="Actual">August 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Choriocapillaris flow area</measure>
    <time_frame>10 minutes</time_frame>
    <description>Choriocapillaris flow area assessed with optical coherence tomography angiography</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Subfoveal choroidal thickness</measure>
    <time_frame>10 minutes</time_frame>
    <description>Subfoveal choroidal thickness assessed with optical coherence tomography angiography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vessel density</measure>
    <time_frame>10 minutes</time_frame>
    <description>Vessel density assessed with optical coherence tomography angiography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Foveal avascular zone</measure>
    <time_frame>10 minutes</time_frame>
    <description>Foveal avascular zone assessed with optical coherence tomography angiography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subfoveal central macular thickness</measure>
    <time_frame>10 minutes</time_frame>
    <description>Subfoveal central macular thickness assessed with optical coherence tomography angiography</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">48</enrollment>
  <condition>Cachexia</condition>
  <condition>Underweight</condition>
  <arm_group>
    <arm_group_label>Underweight</arm_group_label>
    <description>Comprehensive ophthalmologic examination</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>Comprehensive ophthalmologic examination</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Comprehensive ophthalmologic examination</intervention_name>
    <description>Measurements of best-corrected visual acuity, refractive error, intraocular pressure, axial length, slit lamp examination of the anterior segment, dilated fundus examination, and optical coherence tomography angiography imaging.</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Underweight</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Study population includes a convenience sampling from the patients admitted to outpatient&#xD;
        clinic between June 2020 and August 2020.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Underweight (BMI &lt; 18.50 kg/m2).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  refractive error &gt;+3.0 diopters (D) or &lt;-3.0 D spherical equivalent;&#xD;
&#xD;
          -  poor image quality &lt;60 due to unstable fixation&#xD;
&#xD;
          -  IOP &gt; 21 mm Hg&#xD;
&#xD;
          -  longer AL (&gt;25 mm)&#xD;
&#xD;
          -  pre-existing ophthalmic pathologies&#xD;
&#xD;
          -  prior ocular surgery&#xD;
&#xD;
          -  a systemic chronic disease that can cause underweight or retinopathy, such as cancer,&#xD;
             malnutrition, and diabetes mellitus.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Aslı Çentinkaya Yaprak</name>
      <address>
        <city>Antalya</city>
        <zip>070059</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>November 11, 2020</study_first_submitted>
  <study_first_submitted_qc>November 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 17, 2020</study_first_posted>
  <last_update_submitted>November 17, 2020</last_update_submitted>
  <last_update_submitted_qc>November 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Akdeniz University</investigator_affiliation>
    <investigator_full_name>Aslı Çetinkaya Yaprak</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cachexia</mesh_term>
    <mesh_term>Thinness</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

